I have had Eylea injected for a couple of years in both eyes and was switched to Beovu. Largely because I was requiring shots almost every 4 weeks. Shot burden was creating more floaters and higher iop.Beovu Had an amazing effect on my eyes-they felt normal and vision was 20-20. I Only had 2 shots in the loading phase and then the US specialist began seeing adverse events-I think 1 in every 10,000 injections. I was switched back to Eylea but long to try the Beovu again as the Eylea results are not nearly as good. That being said I would like to know if the people who had the adverse events had med histories in common that could pinpoint the reasons for the terrible outcomes. Age? High blood pressure? Blood thinners? Certain meds? I assume Novartis is trying to figure out this as well but as of yet have been unable to find out anything. I read Amelia’s post with interest and am very sorry for her outcome. I wish Novartis could shed more light on this.